APA Alıntı

Pratley, R. E., Aroda, V. R., Catarig, A., Lingvay, I., Lüdemann, J., Yildirim, E., & Viljoen, A. (2020). Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. BMJ Open.

Chicago Stili Alıntı

Pratley, Richard E., Vanita R. Aroda, Andrei-Mircea Catarig, Ildiko Lingvay, Jörg Lüdemann, Emre Yildirim, ve Adie Viljoen. "Impact of Patient Characteristics On Efficacy and Safety of Once-weekly Semaglutide Versus Dulaglutide: SUSTAIN 7 Post Hoc Analyses." BMJ Open 2020.

MLA Alıntı

Pratley, Richard E., et al. "Impact of Patient Characteristics On Efficacy and Safety of Once-weekly Semaglutide Versus Dulaglutide: SUSTAIN 7 Post Hoc Analyses." BMJ Open 2020.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..